Related Experiment Video

Updated: May 23, 2026

Neurogenesis Using P19 Embryonal Carcinoma Cells
07:46

Neurogenesis Using P19 Embryonal Carcinoma Cells

Published on: April 27, 2019

Involvement of P2Y13 receptor in suppression of neuronal differentiation

Shinya Yano1, Mitsutoshi Tsukimoto, Hitoshi Harada

  • 1Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), 3613 Yamazaki, Noda City, Chiba 278-8510, Japan.

Neuroscience Letters
|April 24, 2012
PubMed

Insights

Blocking the P2Y13 receptor with MRS2211 significantly enhanced neuronal differentiation and neurite outgrowth in tested cell lines. This suggests P2Y13 receptor antagonists may aid in treating neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Extracellular ATP (adenosine triphosphate) plays a role in cellular signaling.
  • Neuronal differentiation is crucial for nervous system development and function.
  • The P2Y13 receptor's role in neuronal differentiation is not fully understood.

Purpose of the Study:

  • To investigate the effect of extracellular ATP on neuronal differentiation.
  • To determine the involvement of the P2Y13 receptor in this process.
  • To explore the potential therapeutic applications of P2Y13 receptor antagonists.

Main Methods:

  • Utilized PC12, Neuro2a, and MEB5 cell lines.
  • Administered a series of receptor antagonists, including P2Y13 receptor antagonist MRS2211.
  • Assessed neurite outgrowth as a measure of neuronal differentiation.
  • Examined the activation of ERK1/2 signaling pathway in response to nerve growth factor (NGF) and MRS2211.

Main Results:

  • The P2Y13 receptor antagonist MRS2211 significantly accelerated neurite outgrowth in all tested cell lines.
  • MRS2211 enhanced NGF-induced ERK1/2 activation in PC12 cells.
  • These findings indicate that the P2Y13 receptor suppresses neuronal differentiation.

Conclusions:

  • The P2Y13 receptor is involved in the suppression of neuronal differentiation.
  • P2Y13 receptor antagonists, such as MRS2211, promote neuronal differentiation.
  • P2Y13 receptor antagonists show potential as therapeutic agents for neurodegenerative diseases.

More Related Videos

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...